Navigation Links
Bavarian Nordic A/S - Half Year Interim Report 2009
Date:8/28/2009

nd Phase II trials have suggested a survival benefit after treatment with PROSTVAC(TM), especially in patients with indolent disease characteristics."

A PROSTVAC(TM) abstract has been accepted for an oral presentation at the European CanCer Organisation (ECCO), ECCO 15 - 34th ESMO Congress, taking place in Berlin September 20-24 2009.

Ongoing PROSTVAC(TM) studies

There are a number of ongoing clinical studies with PROSTVAC(TM) in both early and late stage prostate cancer, all of which are funded and conducted by NCI under the ongoing collaboration with Bavarian Nordic.

    Ongoing studies with active patient enrolling:

    - Phase II study comparing the radioactive drug, samarium with or without
      PROSTVAC(TM) therapy in men with metastatic prostate cancer

    - Phase II study comparing antihormone therapy (flutamide) with or
      without PROSTVAC(TM) therapy in men with non-metastatic prostate cancer

    Ongoing studies with enrolment completed:

    - Phase II study investigating PROSTVAC(TM) in men with PSA progress
      after local therapy (surgery and/or radiation)

    - Phase I dose-escalation, combination study with PROSTVAC(TM) and
      MDX-010 (CTL4-antibody) in men with metastatic prostate cancer

    - Phase I study investigating PROSTVAC(TM) by intraprostatic injection in
      patients with progressive or locally recurrent prostate cancer

Forward-looking statements

This announcement includes "forward-looking statements" that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. We undertake no obligation to
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
2. Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
3. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
4. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
5. Bavarian Nordics Case Against Oxford BioMedica
6. Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
7. Bavarian Nordic Publishes its Annual Results 2008
8. Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009
9. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
10. Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE(R)
11. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 18, 2014 Scientists at NYU Langone Medical Center ... efficiency of the process for turning adult cells into ... including vitamin C. Using the new technique in mice, ... from adult skin cells by more than 20-fold compared ... efficient and reliable, and thus should generally accelerate research ...
(Date:9/19/2014)...  Nektar Therapeutics (NASDAQ: NKTR ) ... analgesic profiles of a series of the company,s ... The preclinical research candidates were created using Nektar,s ... The analgesic properties of kappa receptor agonism are ... Kappa opioid receptors are expressed in the peripheral ...
(Date:9/19/2014)... 19, 2014 ... ) has announced the addition of the  "Micro ... to their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... of the fastest-growing segments in the chromatography market. ... 2013, and expected to reach $2.0 billion by ...
(Date:9/18/2014)... About POCT POCT, ... clinical laboratory. It helps in making fast clinical ... medication. POCT is gaining popularity due to the ... as diabetes, heart disease, and obesity. It is ... to minimize errors during the diagnosis of patients. ...
Breaking Biology Technology:NYU Langone scientists report reliable and highly efficient method for making stem cells 2NYU Langone scientists report reliable and highly efficient method for making stem cells 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Micro Market Monitor : Global Pre-packed Chromatography Columns 2POCT Market in China 2014-2018 2
... Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced ... will be presenting a corporate overview at the 2011 ... August 16, 2011, at 8:00 AM ET, in New ... available on the Investors page of Insmed,s website, ...
... and BERGEN, Norway, August 11, 2011 Valkee ... and scientists from the University of Oulu will present new ... Annual Meeting 2011, August 12-14. Their research localized ... - in all of the 18 evaluated areas of the ...
... 10, 2011 Exagen Diagnostics, Inc. , a ... markets proprietary tests for rheumatologists and gastroenterologists, announced today ... Operating Officer. Tornoe has more than 20 ... and marketing, making him a key hire as Exagen ...
Cached Biology Technology:Insmed to Present at 2011 Wedbush Securities Life Sciences Management Access Conference 2The Human Brain is Sensitive to Light, Breakthrough Findings From Valkee and the University of Oulu 2The Human Brain is Sensitive to Light, Breakthrough Findings From Valkee and the University of Oulu 3Eric Tornoe Joins Exagen Diagnostics as President and COO 2
(Date:9/18/2014)... colleagues have built the first smartphone app that ... behavioral trends. In other words, your smartphone knows ... don,t -- and how that affects you. , ... depression and loneliness to their academic performance, also ... for example, to monitor mental health, trigger intervention ...
(Date:9/18/2014)... so you might expect that most would have an ... dogs are distinctly more pessimistic than others, research from ... is exciting because it measures positive and negative emotional ... and dog owners an insight into the outlook of ... from the Faculty of Veterinary Science. Her PhD research ...
(Date:9/18/2014)... The global cycles of carbon and nitrogen comprise ... human and environmental systems have caused imbalances and ... greenhouse gases (GHGs). Increased GHGs result in climate ... terrestrial ecosystems, oceans and the atmosphere. Understanding these ... exciting branch of environmental science during the past ...
Breaking Biology News(10 mins):New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4Dogs can be pessimists too 2Dogs can be pessimists too 3Greenhouse gas research enters a new era 2
... cellsas indicated by a molecular imaging techniquecould tell researchers ... headaches and psychosis in schizophrenic patients, occur and provide ... two studies published in the November issue of the ... positron emission tomography (PET)a noninvasive molecular imaging techniqueresearchers were ...
... When 100 m sprinters launches themselves from the starting blocks, ... few strides. Acceleration through the first few strides is the ... by an American football star, who sprints in his position ... his technique and training regime, Piazza decided to focus on ...
... have confirmed that the largest bat in Europe, ... the Late Pleistocene (between 120,000 and 10,000 years ago). ... at Abrc Roman (Barcelona) prove that this bat had ... than it does today, having declined due to the ...
Cached Biology News:Unlocking mysteries of the brain with PET 2Short heels make elite sprinters super speedy 2The largest bat in Europe inhabited northeastern Spain more than 10,000 years ago 2
... kit for stabilizing 400g of purified RNA ... for the stabilization of aqueous RNA samples ... such as guanidine, phenol/chloroform, silica, oligo dT ... Kits contain all the necessary components for ...
...
... wide mouth PYREX Fernbach-style culture flasks have ... the flask bottom to achieve maximal oxygen ... flasks have a Delong-style 38mm neck for ... For plastic closures see Nos. CLS2679638 or ...
... Fernbach-style culture flask is designed for culturing organisms ... It can also be used in serum production. ... achieve maximal oxygen transfer to culture medium. Beaded ... cotton plugs or No. 13 rubber stoppers. This ...
Biology Products: